Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O’Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leiby, Melanie A, Lubiniecki, Gregory M, Shentu, Yue, Rangwala, Reshma, Brahmer, Julie R
Published in The New England journal of medicine (10.11.2016)
Published in The New England journal of medicine (10.11.2016)
Get full text
Journal Article
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Leal, Ticiana A, Riess, Jonathan W, Jensen, Erin, Zhao, Bin, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (20.07.2021)
Published in Journal of clinical oncology (20.07.2021)
Get full text
Journal Article
Pembrolizumab or Placebo Plus Etoposide and Platinum as First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer: Randomized, Double-Blind, Phase III KEYNOTE-604 Study
Rudin, Charles M, Awad, Mark M, Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K, Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J, Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P, Luo, Yiwen, Ebiana, Victoria, Pietanza, M Catherine, Kim, Hye Ryun
Published in Journal of clinical oncology (20.07.2020)
Published in Journal of clinical oncology (20.07.2020)
Get full text
Journal Article
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
Felip, Enriqueta, Altorki, Nasser, Zhou, Caicun, Csőszi, Tibor, Vynnychenko, Ihor, Goloborodko, Oleksandr, Luft, Alexander, Akopov, Andrey, Martinez-Marti, Alex, Kenmotsu, Hirotsugu, Chen, Yuh-Min, Chella, Antonio, Sugawara, Shunichi, Voong, David, Wu, Fan, Yi, Jing, Deng, Yu, McCleland, Mark, Bennett, Elizabeth, Gitlitz, Barbara, Wakelee, Heather
Published in The Lancet (British edition) (09.10.2021)
Published in The Lancet (British edition) (09.10.2021)
Get full text
Journal Article
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater
Reck, Martin, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Vandormael, Kristel, Riccio, Antonio, Yang, Jing, Pietanza, M Catherine, Brahmer, Julie R
Published in Journal of clinical oncology (01.03.2019)
Published in Journal of clinical oncology (01.03.2019)
Get full text
Journal Article
Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
Paz-Ares, Luis, Luft, Alexander, Vicente, David, Tafreshi, Ali, Gümüş, Mahmut, Mazières, Julien, Hermes, Barbara, Çay Şenler, Filiz, Csőszi, Tibor, Fülöp, Andrea, Rodríguez-Cid, Jerónimo, Wilson, Jonathan, Sugawara, Shunichi, Kato, Terufumi, Lee, Ki Hyeong, Cheng, Ying, Novello, Silvia, Halmos, Balazs, Li, Xiaodong, Lubiniecki, Gregory M, Piperdi, Bilal, Kowalski, Dariusz M
Published in The New England journal of medicine (22.11.2018)
Published in The New England journal of medicine (22.11.2018)
Get full text
Journal Article
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial
Brahmer, Julie R, Rodríguez-Abreu, Delvys, Robinson, Andrew G, Hui, Rina, Csőszi, Tibor, Fülöp, Andrea, Gottfried, Maya, Peled, Nir, Tafreshi, Ali, Cuffe, Sinead, O'Brien, Mary, Rao, Suman, Hotta, Katsuyuki, Zhang, Jin, Lubiniecki, Gregory M, Deitz, Anne C, Rangwala, Reshma, Reck, Martin
Published in The lancet oncology (01.12.2017)
Published in The lancet oncology (01.12.2017)
Get full text
Journal Article
Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial
Di Leo, Angelo, Johnston, Stephen, Lee, Keun Seok, Ciruelos, Eva, Lønning, Per E, Janni, Wolfgang, O'Regan, Ruth, Mouret-Reynier, Marie-Ange, Kalev, Dimitar, Egle, Daniel, Csőszi, Tibor, Bordonaro, Roberto, Decker, Thomas, Tjan-Heijnen, Vivianne C G, Blau, Sibel, Schirone, Alessio, Weber, Denis, El-Hashimy, Mona, Dharan, Bharani, Sellami, Dalila, Bachelot, Thomas
Published in The lancet oncology (01.01.2018)
Published in The lancet oncology (01.01.2018)
Get full text
Journal Article
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
Dasari, Arvind, Lonardi, Sara, Garcia-Carbonero, Rocio, Elez, Elena, Yoshino, Takayuki, Sobrero, Alberto, Yao, James, García-Alfonso, Pilar, Kocsis, Judit, Cubillo Gracian, Antonio, Sartore-Bianchi, Andrea, Satoh, Taroh, Randrian, Violaine, Tomasek, Jiri, Chong, Geoff, Paulson, Andrew Scott, Masuishi, Toshiki, Jones, Jeremy, Csőszi, Tibor, Cremolini, Chiara, Ghiringhelli, Francois, Shergill, Ardaman, Hochster, Howard S, Krauss, John, Bassam, Ali, Ducreux, Michel, Elme, Anneli, Faugeras, Laurence, Kasper, Stefan, Van Cutsem, Eric, Arnold, Dirk, Nanda, Shivani, Yang, Zhao, Schelman, William R, Kania, Marek, Tabernero, Josep, Eng, Cathy
Published in The Lancet (British edition) (01.07.2023)
Published in The Lancet (British edition) (01.07.2023)
Get full text
Journal Article
First-line encorafenib plus binimetinib and pembrolizumab for advanced BRAF V600-mutant melanoma: Safety lead-in results from the randomized phase III STARBOARD study
Dudnichenko, Oleksandr, Penkov, Konstantin, McKean, Meredith, Mandalà, Mario, Kukushkina, Mariia, Panella, Timothy, Csőszi, Tibor, Gerletti, Paola, Thakur, Mahgull, Polli, Anna, di Pietro, Alessandra, Schadendorf, Dirk
Published in European journal of cancer (1990) (01.12.2024)
Published in European journal of cancer (1990) (01.12.2024)
Get full text
Journal Article
Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
Dómine Gómez, Manuel, Csőszi, Tibor, Jaal, Jana, Kudaba, Iveta, Nikolov, Krasimir, Radosavljevic, Davorin, Xiao, Jie, Horton, Janet K., Malik, Rajesh K., Subramanian, Janakiraman
Published in International journal of cancer (01.10.2021)
Published in International journal of cancer (01.10.2021)
Get full text
Journal Article
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial
Yang, James Chih-Hsin, Han, Baohui, De La Mora Jiménez, Emmanuel, Lee, Jong-Seok, Koralewski, Piotr, Karadurmus, Nuri, Sugawara, Shunichi, Livi, Lorenzo, Basappa, Naveen S., Quantin, Xavier, Dudnik, Julia, Ortiz, Diego Moran, Mekhail, Tarek, Okpara, Chinyere E., Dutcus, Corina, Zimmer, Zachary, Samkari, Ayman, Bhagwati, Niyati, Csőszi, Tibor
Published in Journal of thoracic oncology (01.06.2024)
Published in Journal of thoracic oncology (01.06.2024)
Get full text
Journal Article
Trilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy‐induced myelosuppression in patients with small cell lung cancer: Pooled analysis of three randomized phase 2 trials
Ferrarotto, Renata, Anderson, Ian, Medgyasszay, Balazs, García‐Campelo, Maria Rosario, Edenfield, William, Feinstein, Trevor M., Johnson, Jennifer M., Kalmadi, Sujith, Lammers, Philip E., Sanchez‐Hernandez, Alfredo, Pritchett, Yili, Morris, Shannon R., Malik, Rajesh K., Csőszi, Tibor
Published in Cancer medicine (Malden, MA) (01.09.2021)
Published in Cancer medicine (Malden, MA) (01.09.2021)
Get full text
Journal Article
Blood tumor mutational burden and response to pembrolizumab plus chemotherapy in non–small cell lung cancer: KEYNOTE-782
Bar, Jair, Esteban, Emilio, Rodríguez-Abreu, Delvys, Aix, Santiago Ponce, Szalai, Zsuzsanna, Felip, Enriqueta, Gottfried, Maya, Provencio, Mariano, Robinson, Andrew, Fülöp, Andrea, Rao, Suman Bannur, Camidge, D. Ross, Speranza, Giovanna, Townson, Steven M., Kobie, Julie, Ayers, Mark, Dettman, E.J., Hunkapiller, Nathan, McDaniel, Robert, Jung, Byoungsok, Burkhardt, David, Mauntz, Ruth, Csőszi, Tibor
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Published in Lung cancer (Amsterdam, Netherlands) (01.04.2024)
Get full text
Journal Article
Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience
Boér, Katalin, Kahán, Zsuzsanna, Landherr, László, Csőszi, Tibor, Máhr, Károly, Ruzsa, Ágnes, Horváth, Zsolt, Budai, Barna, Rubovszky, Gábor
Published in Pathology oncology research (04.05.2021)
Published in Pathology oncology research (04.05.2021)
Get full text
Journal Article
IMpower010: Primary results of a phase III global study of atezolizumab versus best supportive care after adjuvant chemotherapy in resected stage IB-IIIA non-small cell lung cancer (NSCLC)
Wakelee, Heather A., Altorki, Nasser K., Zhou, Caicun, Csőszi, Tibor, Vynnychenko, Ihor O., Goloborodko, Oleksandr, Luft, Alexander, Akopov, Andrey, Martinez-Marti, Alex, Kenmotsu, Hirotsugu, Chen, Yuh-Min, Chella, Antonio, Sugawara, Shunichi, Gitlitz, Barbara J., Bennett, Elizabeth, Wu, Fan, Yi, Jing, Deng, Yu, McCleland, Mark, Felip, Enriqueta
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Results of a prospective dose intensity and neutropenia prophylaxis evaluation programme (DIEPP) in cancer patients at risk of febrile neutropenia due to myelosuppressive chemotherapy
Mądry, Radosław, Popławska, Lidia, Haslbauer, Ferdinand, Šafanda, Martin, Ghizdavescu, Doru, Benkovicova, Jana, Csőszi, Tibor, Mihaylov, Georgi, Niepel, Daniela, Jaeger, Christine, Frkanova, Iveta, Macovei, Alina, Staudigl, Christine
Published in Wiener Klinische Wochenschrift (01.04.2016)
Published in Wiener Klinische Wochenschrift (01.04.2016)
Get full text
Journal Article
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Kim, Hye Ryun, Awad, Mark M., Navarro, Alejandro, Gottfried, Maya, Peters, Solange, Csőszi, Tibor, Cheema, Parneet K., Rodriguez-Abreu, Delvys, Wollner, Mirjana, Yang, James Chih-Hsin, Mazieres, Julien, Orlandi, Francisco J., Luft, Alexander, Gümüş, Mahmut, Kato, Terufumi, Kalemkerian, Gregory P., Luo, Yiwen, Santorelli, Melissa L., Pietanza, M. Catherine, Rudin, Charles M.
Published in JTO clinical and research reports (01.11.2023)
Published in JTO clinical and research reports (01.11.2023)
Get full text
Journal Article
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial
Powles, Thomas, Oudard, Stephane, Vulsteke, Christof, Fléchon, Aude, Yu, Evan Y, Imai, Kentaro, Homet Moreno, Blanca, Alva, Ajjai, Lazzaro, Mauricio Fernandez, Gatica, Gabriela, Van Aelst, Filip, Machiels, Jean-Pascal, Schallier, Denis, Brust, Leandro, Soares, Joao Paulo Holanda, Cheng, Susanna, Leal, Jose Luis, Ibanez, Carolina, Laguerre, Brigitte, Flechon, Aude, Topart, Delphine, Huillard, Olivier, Gravis, Gwenaelle, Reichardt, Peter, Herden, Jan, Pfister, David, Niegisch, Guenter, Boegemann, Martin, Gakis, Georgios, Neisius, Andreas, Thomas, Christian, Kosa, Judit Erzsebet, Bodoky, Gyorgy, Geczi, Lajos, Frank, Stephen Jay, Kejzman, Daniel, Rosenbaum, Eli, Rouvinov, Keren, Arai, Gaku, Takayama, Tatsuya, Fujimoto, Kiyohide, Tanikawa, Toshiki, Tomita, Yoshihiko, Nishimura, Kazuo, Tsujihata, Masao, Takano, Toshimi, Joraku, Akira, Kobayashi, Kazuki, De Wit, Ronald, Aarts, Maureen, Beerepoot, Laurens, Alekseev, Sergey M, Zyryanov, Alexander, Oschepkov, Vasiliy Nikolaevich, Shidin, Vladimir Aleksandrovich, Karlov, Petr Alexandrovich, Cohen, Graham Lawrence, Ruff, Paul, Lee, Nari, Rodriguez-Vida, Alejo, Grande, Enrique, Munoz Langa, Jose, Montesa Pino, Alvaro, Su, Wen-Pin, Chang, Yen-Hwa, Huang, Yi-Hsiu, Srimuninnimit, Vichien, Abali, Huseyin, Sendur, Mehmet Ali Nahit, Ozguroglu, Mustafa, Ozdogan, Mustafa, Evans, Linda, Hussain, Syed, DiSimone, Christopher, Schlegel, Peter, Mamtani, Ronac, Wallace, James, Suh, Jason Jung-Gon, Burgess, Earle, Wong, John, Chaudhry, Arvind, Thomas, Christian A, Fitzharris, John T, Oliff, Ira A, Vuky, Jacqueline, Hauke, Ralph, Joshi, Monika, Bolemon, Britt H, Markus, Maurice, Pfanzelter, Nicklas, Lawler, William Eyre, Courtright, Jay G, Doshi, Gurjyot, Sartor, Oliver Alton, Mannuel, Heather D, Alva, Ajjai, Charles, Anthony, Ades, Steven, Yu, Evan, Fleming, Mark
Published in The lancet oncology (01.07.2021)
Published in The lancet oncology (01.07.2021)
Get full text
Journal Article